Anti-metastatic activity in vivo of MDP-l-alanyl-cholesterol (MTP-Chol) entrapped in nanocapsules
- 1 January 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (2-3), 167-173
- https://doi.org/10.1016/0192-0561(91)90095-o
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effect on Cerebral Blood Flow of Orally Administered Indomethacin-loaded Poly(isobutylcyanoacrylate) and Poly(DL-lactide) NanocapsulesJournal of Pharmacy and Pharmacology, 1990
- Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptideBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptideCancer Immunology, Immunotherapy, 1989
- Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells.The Journal of Immunology, 1988
- New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrierDiabetes, 1988
- Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.The Journal of Immunology, 1987
- Use of mannosylated liposomes for in vivo targeting of a macrophage activator and control of artificial pulmonary metastasesAnnales de l'Institut Pasteur / Immunologie, 1987
- Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsulesInternational Journal of Pharmaceutics, 1986
- Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouseInternational Journal of Immunopharmacology, 1979
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974